v3.26.1
Consolidated Statement of Changes in Equity - USD ($)
Total
Common Shares [member]
Warrants [member]
Share-based payments reserve [member]
Accumulated Other Comprehensive Loss [member]
Accumulated Deficit [member]
Beginning balance (in shares) at Dec. 31, 2022 35,230,551 35,230,551        
Beginning balance at Dec. 31, 2022 $ 130,186,571 $ 235,611,237 $ 604,000 $ 63,924,814 $ (70,332,349) $ (99,621,131)
Deferred share units 4,650,337     4,650,337    
Deferred share units exercised   $ 400,000   (400,000)    
Deferred share units exercised (in shares)   25,000        
Option vesting 180,587     180,587    
Option exercise 2,497,500 $ 6,476,491   (3,978,991)    
Option exercise (in shares)   330,750        
Option expiry       (96,500)   96,500
Loss and comprehensive income (loss) for the year $ (8,294,334)       4,912,866 (13,207,200)
Ending balance (in shares) at Dec. 31, 2023 35,586,301 35,586,301        
Ending balance at Dec. 31, 2023 $ 129,220,661 $ 242,487,728 604,000 64,280,247 (65,419,483) (112,731,831)
Initial Public Offering 30,000,000 $ 30,000,000        
Initial Public Offering (in shares)   2,000,000        
Share issuance costs (2,539,195) $ (2,539,195)        
Deferred share units 11,100,686     11,100,686    
Deferred share units exercised   $ 2,733,328   (2,733,328)    
Deferred share units exercised (in shares)   173,958        
Restricted share units 25,853,678     25,853,678    
Restricted share units exercised   $ 460,225   (460,225)    
Restricted share units exercised (in shares)   31,875        
Option vesting 2,970     2,970    
Option exercise 2,057,500 $ 6,019,398   (3,961,898)    
Option exercise (in shares)   489,166        
Option expiry       (566,620)   566,620
Warrants issued 459,500   459,500      
Warrant exercise 1,614,750 $ 2,134,649 (519,899)      
Warrant exercise (in shares)   122,437        
Loss and comprehensive income (loss) for the year $ (62,350,264)       (15,941,811) (46,408,453)
Ending balance (in shares) at Dec. 31, 2024 38,403,737 38,403,737        
Ending balance at Dec. 31, 2024 $ 135,420,286 $ 281,296,133 543,601 93,515,510 (81,361,294) (158,573,664)
Common shares issued in private placement financing 12,880,012 $ 12,880,012        
Common shares issued in private placement financing (in shares)   9,450,000        
Pre-funded warrants issued in private placement financing 6,198,948   6,198,948      
Share issuance costs (1,355,370) $ (915,093) (440,277)      
Deferred share units 2,321,445     2,321,445    
Deferred share units exercised   $ 15,467,160   (15,467,160)    
Deferred share units exercised (in shares)   962,500        
Restricted share units 40,747,669     40,747,669    
Restricted share units exercised   $ 13,321,000   (13,321,000)    
Restricted share units exercised (in shares)   900,000        
Option exercise 40,000 $ 120,511   (80,511)    
Option exercise (in shares)   10,000        
Option expiry       (12,091,112)   12,091,112
Warrant expiry     (543,601)     543,601
Common shares purchased under equity line of credit, net of issuance costs 5,999,500 $ 5,999,500        
Common shares purchased under equity line of credit, net of issuance costs (in shares)   3,750,000        
Common shares issued for equity line of credit 375,000 $ 375,000        
Common shares issued for equity line of credit (in shares)   215,852        
Loss and comprehensive income (loss) for the year $ (44,789,761)       7,369,359 (52,159,120)
Ending balance (in shares) at Dec. 31, 2025 53,692,089 53,692,089        
Ending balance at Dec. 31, 2025 $ 157,837,729 $ 328,544,223 $ 5,758,671 $ 95,624,841 $ (73,991,935) $ (198,098,071)